clonazepam

New Research from the CWMH: Risk of Major Malformations in Infants with Prenatal Exposure to Benzodiazepines

Data from an ongoing pregnancy registry offers reassurance that benzodiazepines do not appear to have major teratogenic effects.

By |2023-06-27T17:47:46-04:00June 26th, 2023|Anti-Anxiety Medications, Outcomes, Pregnancy & Medications, Research at CWMH, Risk of Malformations|Comments Off on New Research from the CWMH: Risk of Major Malformations in Infants with Prenatal Exposure to Benzodiazepines

Essential Reads: Prenatal Exposure to Benzodiazepines and Neurodevelopmental Outcomes

The largest study to date observes no increase in risk of autism or ADHD in children with prenatal exposure to benzodiazepines.

By |2022-12-09T12:49:22-04:00December 9th, 2022|Anti-Anxiety Medications, Essential Reads, Neurodevelopmental Disorders, Pregnancy & Medications|Comments Off on Essential Reads: Prenatal Exposure to Benzodiazepines and Neurodevelopmental Outcomes

Essential Reads: Neurodevelopmental Outcomes in Children with Prenatal Exposure to Benzodiazepines and Z-Drugs

Our data regarding prenatal exposure to BZDs and/or z-drugs and risk of neurodevelopmental outcomes is still sparse.

By |2022-05-19T08:37:21-04:00May 19th, 2022|Anti-Anxiety Medications, Essential Reads, Neurodevelopmental Disorders, Pregnancy & Medications, Sleep Medications|Comments Off on Essential Reads: Neurodevelopmental Outcomes in Children with Prenatal Exposure to Benzodiazepines and Z-Drugs

Interpreting New Data on the Use of Benzodiazepines During Pregnancy

Data regarding the reproductive safety of benzodiazepines has always been somewhat difficult to understand.  While earlier studies suggested an association between prenatal exposure to benzodiazepines and increased risk of cleft lip and palate, more recent [...]

By |2019-12-09T22:36:51-04:00December 10th, 2019|Anti-Anxiety Medications, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Interpreting New Data on the Use of Benzodiazepines During Pregnancy

Benzodiazepine During Early Pregnancy and Risk of Miscarriage

Many women who come to our clinic with questions regarding the use of medications during pregnancy suffer from some type of anxiety disorder.  Most of those women benefit from treatment with an SSRI or SNRI [...]

By |2019-06-10T23:35:58-04:00June 11th, 2019|Anti-Anxiety Medications, Pregnancy & Medications, Pregnancy Loss|Comments Off on Benzodiazepine During Early Pregnancy and Risk of Miscarriage

New Research from the CWMH: Obstetrical and Neonatal Outcomes with Benzodiazepine Exposure During Pregnancy

Recent studies have demonstrated that more than 10% of women experience clinically significant symptoms of anxiety during pregnancy, particularly during the first trimester.  Anxiety during pregnancy is not necessarily a benign event.  Various studies indicate [...]

By |2018-08-09T11:56:54-04:00August 2nd, 2018|Pregnancy & Medications, Research at CWMH|Comments Off on New Research from the CWMH: Obstetrical and Neonatal Outcomes with Benzodiazepine Exposure During Pregnancy

Prenatal Valproic Acid Exposure and Poor School Performance in Older Children

  There have long been concerns regarding the use of the anticonvulsant valproate (Depakote) during pregnancy.  First trimester use of valproate has been associated with a 3-5% risk of neural tube defects, as well as [...]

By |2025-06-26T09:07:50-04:00April 17th, 2018|Pregnancy & Medications|Comments Off on Prenatal Valproic Acid Exposure and Poor School Performance in Older Children

Prenatal Exposure to Benzodiazepines and Sedative-Hypnotics

Over the last decade, we have seen multiple studies looking at the long term effects of prenatal exposure to antidepressants, particularly the selective serotonin reuptake inhibitors or SSRIs, on children's behavior.  Although benzodiazepines, such as [...]

By |2020-01-07T16:57:49-04:00August 31st, 2017|Anti-Anxiety Medications, Pregnancy & Medications, Sleep Medications|Comments Off on Prenatal Exposure to Benzodiazepines and Sedative-Hypnotics

SSRIs and Benzodiazepines: Reproductive Safety of Combined Treatment

Serotonin reuptake inhibitors (SSRIs) are frequently combined with benzodiazepines for the management of anxiety disorders or major depression with comorbid anxiety.  While we have data regarding the reproductive safety of both the SSRIs and benzodiazepines, we have much less information on outcomes in women taking SSRIs and benzodiazepines together.  A previous study (Oberlander 2008) found that neither the use of an SSRI alone nor the use of a benzodiazepine alone increased the risk for congenital malformation; however, in this study, the combined use of the two drugs increased the risk of cardiovascular defect. A recent study reassesses the risk of major malformation in women taking SSRIs combined with benzodiazepines.

By |2015-08-06T09:31:18-04:00June 12th, 2013|Pregnancy & Medications|Comments Off on SSRIs and Benzodiazepines: Reproductive Safety of Combined Treatment
Go to Top